Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;72(1):287-304.
doi: 10.1002/hep.31281.

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement

Oren K Fix  1 , Bilal Hameed  2 , Robert J Fontana  3 , Ryan M Kwok  4 , Brendan M McGuire  5 , David C Mulligan  6 , Daniel S Pratt  7 , Mark W Russo  8 , Michael L Schilsky  6 , Elizabeth C Verna  9 , Rohit Loomba  10 , David E Cohen  11 , Jorge A Bezerra  12 , K Rajender Reddy  13 , Raymond T Chung  7
Affiliations

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement

Oren K Fix et al. Hepatology. 2020 Jul.

Abstract

Background and aims: Coronavirus disease 2019 (COVID-19), the illness caused by the SARS-CoV-2 virus, is rapidly spreading throughout the world. Hospitals and healthcare providers are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to manage this new disease. The goals of this document are to provide data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers.

Approach and results: This article discusses what is known about COVID-19 with a focus on its impact on hepatologists, liver transplant providers, patients with liver disease, and liver transplant recipients. We provide clinicians with guidance for how to minimize the impact of the COVID-19 pandemic on their patients' care.

Conclusions: The situation is evolving rapidly, and these recommendations will need to evolve as well. As we learn more about how the COVID-19 pandemic impacts the care of patients with liver disease, we will update the online document available at https://www.aasld.org/about-aasld/covid-19-and-liver.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Approach to the patient with COVID‐19 and elevated serum liver biochemistries.
FIG. 2
FIG. 2
Approach to LT organ offers.
FIG. 3
FIG. 3
Approach to the LT recipient with COVID‐19.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708‐1720. - PMC - PubMed
    1. Chopra V, Toner E, Waldhorn R, Washer L. How should U.S. hospitals prepare for coronavirus disease 2019 (COVID‐19)? Ann Intern Med 2020;172:621‐622. - PMC - PubMed
    1. Centers for Disease Control and Prevention . Coronavirus disease 2019 (COVID‐19): cleaning and disinfection for community facilities. Published February 11, 2020. https://www.cdc.gov/coronavirus/2019‐ncov/community/organizations/cleani.... Accessed April 2020.
    1. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS‐CoV‐2. Gastroenterology 2020;158:1831‐1833.e3. - PMC - PubMed
    1. Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. Prolonged presence of SARS‐CoV‐2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020;5:434‐435. - PMC - PubMed

MeSH terms